Bruker Daltonics Announces PharmaTools Product Suite.Business Editors/Health/Medical Writers 52nd ASMS ASMS American Society for Mass Spectrometry ASMS Association of Salaried Medical Specialists ASMS Advanced Satellite Mobile Systems ASMS Alabama School of Mathematics and Science ASMS American Society for Mohs Surgery ASMS Arkansas School for Math and Science Conference NASHVILLE, Tenn.--(BUSINESS WIRE)--May 24, 2004 Bruker Daltonics, an operating company operating company A business that engages in transactions with outsiders. of Bruker BioSciences Corporation Bruker Biosciences Corporation is a Massachusetts-based company formed in 2003 which develops and manufactures scientific instrumentation for academic research and industrial use. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BRKR BRKR Breaker ), announces the PharmaTools(TM) suite of products for the drug industry at the 52nd ASMS conference. The PharmaTools products are primarily tailored towards the demanding requirements of customers in the pharmaceutical and biotech industries who require very high reliability and uptime, excellent training, service and support, and vendor assistance for operating in a regulated environments. PharmaTools Natural Products Multiparameter Libraries An important new capability in PharmaTools is a new library search capability, that includes a setup to automatically build up libraries, e.g. for natural compounds, have multi-user access to the library (e.g. from various countries), and automatically screen for compounds in the library. The specificity is enhanced by combined searches with positive/negative polarity ESI-measurements, as well as MS and MS/MS MS/MS Tandem Mass Spectroscopy MS/MS Multistage Mass Spectrometry data of the same compound. These libraries can be particularly powerful in drug discovery. PharmaTools Open Access Environment Bruker Daltonics introduced its Compass(TM) integrated software environment for all of its life-science mass spectrometers one year ago. Compass makes it easy to run different types of Bruker systems in the same laboratory, as they share the same acquisition graphical user interfaces, and use identical processing, analysis and bioinformatics software under the Compass umbrella. Bruker Daltonics now announces Compass OA, an open access environment for multi-user environments, particularly in large or medium sized pharma or biotech companies. Compass OA allows untrained customers to submit their samples for measurements via a very intuitive simplified acquisition user interface that guides the user step-by-step. Compass OA then also distributes the acquired data and provides powerful visual tools for data interpretation and quick assessment of the results back to the users. Metabolic Profiler(TM) For Efficacy and Toxicity Studies The new Metabolic Profiler is a system developed jointly by Bruker Daltonics and Bruker Biospin to study metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions as surrogate markers for efficacy, or to assess toxicity early on in drug development. Metabolic profiles are compared and differences detected on individual samples or patient cohorts. Samples are analyzed by microTOF(TM) ESI-TOF mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. and/or one-dimensional flow-NMR, and jointly analyzed in one powerful analysis package. PharmaTools Validation Products The PharmaTools suite offers the validation products IQ (installation qualification) and OQ/PV (operational qualification and performance verification). These products increase productivity by ensuring consistent performance of the instruments over time. For customers in regulated environments, the PharmaTools suite now includes support software for 21 CFR CFR See: Cost and Freight Part 11 compliance, including audit trails, user management, result history, electronic signatures, and data security. PharmaTools Training, Support and Service Products Highest quality training, support and service are key to help our pharma customers achieve the utmost in productivity and uptime. We now offer various levels of maintenance service contracts (MSAs), including optional 24/7 coverage, as well as a new preventive maintenance (PM) program, along with the customary per-call service. In recent years, Bruker Daltonics has considerably expanded its global service and support network in order to provide whatever level of service support is required by global pharma companies, or individual pharma or biotech sites. Service can now also be provided via remote diagnostics, often accelerating the process of getting customers up and running again. With PharmaTools, our broadened customer training program now includes options for training courses at our applications laboratories, via internet webex sessions, or on-site. Dr. Michael Schubert, Vice President for R&D at Bruker Daltonics, stated: "The introduction of our PharmaTools suite is a significant step in our development of solutions to meet customer requirements. We are now in an excellent position to expand the use of our high-information content tools within drug discovery. Moreover, we now offer a broad range of tools also for drug development, and even pharma QA/QC QA/QC Quality Assurance/Quality Control , where reliability, validation, service support and creative functional solutions for specific requirements are particularly important. Our easy-to-use, integrated Compass software environment further enhances the productivity for many PharmaTools applications." ABOUT BRUKER BIOSCIENCES Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com. CAUTIONARY STATEMENT Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's reorganization strategies, integration risks, failure of conditions, technological approaches, product development, market acceptance, cost and pricing of the Company's products, changes in governmental regulations, capital spending capital spending Spending for long-term assets such as factories, equipment, machinery, and buildings that permits the production of more goods and services in future years. and government funding policies, FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. and other regulatory approvals to the extent applicable, competition, the intellectual property of others, patent protection and litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. . These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2003, our most recent quarterly reports on Form 10-Q Form 10-Q See 10-Q. and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion